SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-038152
Filing Date
2024-12-20
Accepted
2024-12-20 17:12:25
Documents
16
Period of Report
2024-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20241217_8k.htm   iXBRL 8-K 44360
2 EXHIBIT 10.1 ex_758810.htm EX-10.1 196995
3 EXHIBIT 99.1 ex_758563.htm EX-99.1 14326
  Complete submission text file 0001437749-24-038152.txt   462666

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clnn-20241217.xsd EX-101.SCH 3945
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20241217_def.xml EX-101.DEF 13906
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20241217_lab.xml EX-101.LAB 18376
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20241217_pre.xml EX-101.PRE 13938
18 EXTRACTED XBRL INSTANCE DOCUMENT clnn20241217_8k_htm.xml XML 5061
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

IRS No.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 241568892
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)